Best Saxenda Alternatives in 2026 (Cheaper, Weekly, and Often More Effective)

If you’re looking for the best Saxenda alternatives, here’s the short version. For most adults, the strongest swap is Zepbound (tirzepatide) for the biggest average weight loss, or Wegovy (semaglutide) if you want a proven weekly shot with more ways to use insurance. Both showed more average weight loss than Saxenda in the trials. Both are once a week instead of every day. And here’s the part that surprises people: bought as cash through the drugmakers’ own pharmacies, both are cheaper than Saxenda’s $1,349 list price while delivering roughly twice the average weight loss.

Want the same medicine as Saxenda for less money? Ask about generic liraglutide. Done with needles? Wegovy’s pill and Foundayo are FDA-approved options you swallow. Can’t take a GLP-1 at all? There are solid non-GLP-1 backups too.

The real question isn’t “what can I take instead of Saxenda?” It’s which alternative fits the reason you’re leaving Saxenda — and what it’ll actually cost you. Here’s the fast way to find yourself:

• Want the most weight loss? → Zepbound (tirzepatide), a weekly shot.
• Want a weekly shot with the most insurance options? → Wegovy (semaglutide).
• Done with needles? → Wegovy pill or Foundayo (both taken by mouth).
• Saxenda worked, but it costs too much? → Generic liraglutide (same medicine, lower price).
• Can’t take a GLP-1? → Ask about Qsymia, Contrave, or orlistat (non-GLP-1 pills).

A quick note on the term. A GLP-1 is a hormone your gut releases after you eat that tells your brain you’re full. These medications copy that hormone so you feel satisfied on less food. Saxenda (liraglutide) was one of the first. The newer drugs work those same appetite signals more strongly — and Zepbound works on two of those signals (called GIP and GLP-1) instead of one, which is part of why it shows stronger results in studies.

What are the 5 best Saxenda alternatives in 2026?

The best Saxenda alternatives for most U.S. adults are Zepbound, Wegovy (pen or pill), Foundayo, and generic liraglutide. Zepbound shows about 21% average weight loss in its main trial — the most of any FDA-approved weight-loss drug so far. Wegovy is the broadest weekly semaglutide option. The Wegovy pill and Foundayo are the FDA-approved no-needle choices. Generic liraglutide is the closest cheaper version of Saxenda itself. The right pick depends on why you’re switching.

We built the table below from FDA labeling, the actual clinical trials, and current prices pulled from the drugmakers’ own pharmacies. All prices verified June 17, 2026 — see the verification box and sources at the bottom.

A clinician decides what’s appropriate. Ro’s free GLP-1 Insurance Coverage Checker is open to everyone — no prescription needed.

Why are people switching off Saxenda?

Most people leave Saxenda for one of four practical reasons: it’s a daily shot, newer drugs work better, the price stings, or their insurance changed. Saxenda is FDA-approved and it does work — people lose roughly 6–8% of body weight on average (SCALE trial). But compared with newer options, it’s the only one in the leading group you inject every single day, and it shows the least weight loss. That combination is why “alternatives” usually means “something better.”

Let’s be fair to Saxenda first. It’s legitimate. If it’s working for you, you tolerate it, and you can afford it, there’s no rule that says you must switch. The reasons to look around are specific and personal — and naming yours is how you pick the right replacement.

It’s daily — most alternatives are weekly or a pill

Saxenda is injected once a day. Wegovy and Zepbound are once a week. The Wegovy pill and Foundayo are once-daily tablets. The one alternative that’s also a daily injection is generic liraglutide — because it’s the same medicine as Saxenda. For a lot of people, going from seven shots a week to one — or to no shots — is the entire motivation.

It works, but newer options work more

This isn’t hype, it’s a head-to-head trial. In the STEP 8 study, semaglutide (Wegovy) produced about 2.4 times more weight loss than liraglutide (Saxenda) — roughly 15.8% versus 6.4% over 68 weeks (JAMA, 2022). Tirzepatide (Zepbound) goes higher still, around 21% at its top dose. We break those numbers down in the next section.

Cost and coverage can flip your “best” overnight

Insurance plans don’t all cover the same drugs, and some are tightening weight-loss coverage. One person’s best alternative is the one their plan will pay for. Another person’s best alternative is the cheapest cash price for an FDA-approved drug. Both are valid — they’re just different starting points.

Common reasons people search for a Saxenda alternative — each one points to a different answer below:

• “It’s daily and I’m just tired of it.”
• “It got too expensive, so I’m looking at what’s cheaper.”
• “My plan covers Wegovy but not Zepbound — so now what?”
• “Is the generic actually the same thing or not?”

Saxenda vs Wegovy vs Zepbound: which replacement actually wins?

For raw weight loss, the order is clear: Zepbound leads (~16–21%), Wegovy is next (~15%), and Saxenda trails (~6–8%). All three are FDA-approved. The two newer ones are weekly, not daily. But “most weight loss” and “best for you” aren’t always the same drug — coverage, side effects, and price decide the real-world answer.

The trial numbers, plainly:

• Saxenda (liraglutide 3.0 mg): about 8% average weight loss; roughly 8 kg lost versus 2.6 kg on placebo in one 56-week study (SCALE).
• Wegovy (semaglutide 2.4 mg): about 14.9% average weight loss at 68 weeks versus 2.4% on placebo (STEP 1, NEJM 2021); 15.8% versus Saxenda’s 6.4% in the head-to-head STEP 8.
• Zepbound (tirzepatide): about 16% to 21% average weight loss depending on dose (SURMOUNT-1, NEJM 2022).

A quick word on side effects: all GLP-1s can cause nausea, and sometimes vomiting, diarrhea, or constipation — usually worst when you first start or step up a dose. Switching drugs can mean starting that slow ramp again. It’s manageable for most people, but it’s real. See who should not use Saxenda alternatives for the full safety picture.

Related: Wegovy vs. Zepbound vs. Saxenda: full breakdown · Zepbound vs. Wegovy head-to-head

Is there a generic for Saxenda?

Yes. The FDA approved generic liraglutide for weight management in August 2025 — the first-ever generic GLP-1 for weight loss, launched by Teva. Because it’s an FDA-approved generic (not a compounded copy), it’s the same active ingredient as Saxenda and is treated as therapeutically equivalent — just made by a different company, which usually means a lower price.

This is the one place on this page where “the same as Saxenda” is actually true and allowed to say — because an approved generic is the same medicine. (That wording is off-limits for compounded drugs, which we cover below.)

What generic liraglutide solves: cost and brand access. If Saxenda worked for you and your only real problem was the price tag, this is the closest swap there is.

What it doesn’t solve: it’s still liraglutide, and it’s still a daily injection. So if your reason for leaving was “I want a weekly shot,” “I want a pill,” or “I want bigger results,” the generic won’t scratch that itch. It’s a cheaper Saxenda — not a stronger or more convenient one.

One reality check on price: at launch, the generic’s list price sat around $1,165 a month — not dramatically below brand Saxenda. The cheaper routes are pharmacy discount coupons and Teva’s own savings program, which says eligible commercially insured patients may pay as little as $20 per prescription. Prices can shift as supply and discount programs change, so verify the exact cash or coupon price at your pharmacy before you count on it.

The best Saxenda alternatives without injections (oral options)

The two FDA-approved no-needle alternatives to Saxenda in 2026 are the Wegovy pill (oral semaglutide) and Foundayo (orforglipron). Both are real, reviewed, FDA-approved weight-management drugs you take by mouth — not compounded “drops” or lozenges. The Wegovy pill starts around $149/month; Foundayo is the newest option, approved April 1, 2026.

Wegovy pill (oral semaglutide)

The tablet version of the same medicine in the Wegovy shot, and it works about as well: roughly 14% average weight loss at 64 weeks — and about 17% for people who stayed on treatment in the OASIS 4 trial. The trade-off is a strict routine: take it on an empty stomach with no more than about 4 ounces of plain water, then wait at least 30 minutes before any food, drink, or other pills. Miss that window and it absorbs poorly. The full weight-loss effect comes at the 25 mg maintenance dose, after about three months of stepping up.

Self-pay pricing: $149/month for the starting and 4 mg doses (the 4 mg price rises to $199 after August 31, 2026), and $299/month for the 9 mg and 25 mg tablets. It’s often the cheapest brand-name route of all.

More detail: how to get the Wegovy pill online

Foundayo (orforglipron)

Eli Lilly’s once-daily GLP-1 pill, FDA-approved April 1, 2026 for adults with obesity, or overweight plus a weight-related condition. In its main 72-week trial, average weight loss ran from about 7.4% to 11.1% across the approved tablet doses — about 25 pounds at the top 17.2 mg dose (Trial 1). Its edge over the Wegovy pill is convenience: you can take it any time of day, with or without food, no water rule — no empty-stomach timing.

Self-pay runs from $149/month at the lowest dose up to about $349/month at the highest; people with eligible commercial insurance may pay $25/month with the savings card. The trade-off is simply that it’s new, so it has the shortest real-world track record.

More detail: Foundayo cost without insurance · best Foundayo providers

One thing to keep straight

Don’t confuse these FDA-approved pills with compounded “oral semaglutide,” sublingual drops, or GLP-1 gum advertised cheaply online. The Wegovy pill and Foundayo have FDA labels, set doses, and safety review behind them. Compounded products don’t — and that’s a meaningful difference we cover below.

If you can’t take a GLP-1: the best non-GLP-1 options

If a GLP-1 is off the table — because of side effects, a medical reason, cost, or plain preference — the leading FDA-approved non-GLP-1 weight-loss drugs are Qsymia, Contrave, orlistat, and phentermine. They work differently than Saxenda and generally produce less weight loss, but for the right person they’re a solid, legitimate path. Qsymia averages around 9–10% in studies; the others are lower.

• Qsymia (phentermine + topiramate): the strongest non-GLP-1 pill, around 9–10% average weight loss. The maker lists it at about $89/month for a 30-day prescription. Not for everyone — it carries its own cautions, including in pregnancy.
• Contrave (naltrexone + bupropion): a daily pill, roughly 5% average loss; can help with appetite and cravings. Pricing varies widely by pharmacy and savings program.
• Phentermine: an older appetite suppressant, FDA-approved for short-term use only, and cheap — often around $15/month with a coupon.
• Orlistat (Xenical by prescription, Alli over the counter): the closest thing to an OTC option, but modest results (~3–5%) and GI side effects if you eat fatty meals. Alli runs roughly $50–$60 for a starter pack.

There’s no over-the-counter version of Saxenda itself, and “natural GLP-1” supplements aren’t proven stand-ins for prescription medication. If you genuinely can’t use a GLP-1, that’s a real reason to look here, and it’s worth a conversation with a clinician who treats obesity.

What’s the cheapest Saxenda alternative — with and without insurance?

The cheapest effective Saxenda alternative in 2026 is usually a brand-name GLP-1 bought direct: the Wegovy pill from $149/month, Zepbound vials from $299/month, or the Wegovy pen at $349/month through the makers’ pharmacies. All three beat Saxenda’s $1,349 list price, and most beat or match its best discount-coupon price too. With commercial insurance and a savings card, Wegovy and Zepbound can drop to as little as $25/month.

The quiet truth most pages miss: the better drug is usually the cheaper one now too. Here’s the comparison:

Sources: NovoCare; Eli Lilly. Prices and offer dates change — re-check before you buy.

A few money notes that matter:

• With commercial insurance: ask about the manufacturer savings card for Wegovy or Zepbound, which can bring eligible patients to about $25/month. The catch is prior authorization, which often needs documentation from your clinician.
• HSA/FSA dollars: an FDA-approved GLP-1 prescribed for a medical condition is generally an eligible expense, so many people can use pre-tax HSA or FSA funds — check your plan’s rules.
• On Medicare or Medicaid: standard Medicare Part D generally still does not cover GLP-1s prescribed only for weight loss. But starting July 1, 2026, a separate federal demonstration called the Medicare GLP-1 Bridge is set to let eligible Part D members get certain GLP-1s for about $50/month (CMS). Medicaid access under a related program (the BALANCE Model) can begin as early as May 2026 and depends on your state.

Prices change monthly — check today’s number before you decide.

Who should not use Saxenda alternatives?

These medications are powerful, and they’re not right for everyone. Saxenda, Wegovy, Zepbound, and Foundayo all carry the FDA’s most serious “boxed” warning about a risk of thyroid C-cell tumors, including a type of thyroid cancer, seen in animal studies. They should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2 (a rare inherited condition that raises tumor risk).

Before you switch, this is the safety picture a clinician will walk through with you. Don’t self-start any of these.

How to switch off Saxenda safely

You switch from Saxenda with a clinician’s guidance — not by stacking two GLP-1s or guessing a dose conversion. The plan depends on your current dose, how you tolerated Saxenda, your medical history, any diabetes medications, and what your insurance or budget can support. Most clinicians stop Saxenda first, then start the new drug at a low dose and step up slowly to limit nausea.

Don’t just stop and start on your own

Talk to a prescriber before you switch. The exact timing and starting dose is a medical decision — not a do-it-yourself one.

Bring this to your appointment

Walk in ready and you’ll get a better plan in less time. Jot down:

• Your current Saxenda dose and your last injection date
• Any side effects you’ve had
• Your weight trend (and recent labs, if you have them)
• A screenshot of your insurance drug list, if you can find it
• Your monthly budget ceiling
• Your main reason for switching (cost, results, side effects, needles, coverage, or wanting a pill)

Questions worth asking

• Should I stop Saxenda before starting the new one?
• What starting dose makes sense for me?
• Which side effects mean I should pause or call you?
• Do my history or medications change the choice?
• If insurance denies my first pick, what’s the backup?

Which Saxenda alternative fits your situation?

The best Saxenda alternative is the one that solves your specific reason for leaving. Find yourself in the table, then take it to a clinician.

No single drug wins for everyone — and that’s actually good news. It means there’s a fit for almost every reason you might be leaving Saxenda.

More resources: best GLP-1 for sleep apnea · best GLP-1 online programs

What about compounded GLP-1 “alternatives”?

Compounded GLP-1s are not FDA-approved, are not generics, and in 2026 the large-scale pathway that supplied them is being restricted. “Compounded” means custom-mixed by a pharmacy without FDA approval, review, or guaranteed sourcing. On April 30, 2026, the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the list large compounding pharmacies may use, finding no clinical need to compound them now that approved versions are available — and the shortages that previously allowed that compounding have already ended.

Here’s why this matters for you specifically, since you’re starting from an FDA-approved medicine.

Compounded is not the same as generic. A generic (like generic liraglutide) is FDA-approved and is the identical medicine. A compounded drug is mixed by a pharmacy without that approval or oversight. They are not interchangeable, and no honest page should call a compounded product “the same as” Saxenda, Wegovy, or Zepbound.

The 2026 rules, accurately. The semaglutide shortage ended in February 2025, the tirzepatide shortage in 2024. The FDA’s April 30, 2026 proposal would close the remaining bulk compounding pathway if finalized; the public comment period ran through June 29, 2026, and final agency action is still pending. The FDA has also warned telehealth companies about misleading compounded GLP-1 marketing, including claims that imply a compounded product is “the same as” the brand.

Our take: because you’re choosing a replacement for an FDA-approved drug, and because this category’s future is uncertain, we don’t recommend leading with compounded GLP-1s here. If cost is your barrier, the durable answers are generic liraglutide, the maker’s cash pricing (Wegovy from $149, Zepbound from $299), or insurance help — all FDA-approved. Compounding is something to discuss only with a licensed clinician, in specific cases where an approved option isn’t appropriate or available.

Full context: compounded GLP-1 vs. name brand

Where to actually start: Ro, Sesame, or manufacturer-direct

For an FDA-approved GLP-1 alternative with insurance help, a telehealth program like Ro is the most complete path — it carries Wegovy, Zepbound, and Foundayo, runs your prior authorization for you, and offers a free insurance coverage checker. If you’d rather pick your own clinician or use Costco-member pricing, Sesame is the better secondary route. If you already have a prescriber, buying direct from NovoCare or LillyDirect is the cheapest pure-cash option.

Why Ro for most switchers: it’s built for exactly this moment. You can check eligibility, get a clinician’s review, and hand off the insurance prior-authorization paperwork to Ro’s team instead of fighting your insurer yourself. Ro also matches the same cash prices as the manufacturer pharmacies (NovoCare and LillyDirect), so you’re not paying a markup on the medication itself.

Ro’s Body program starts at $39 for your first month, then $149/month — or as low as $74/month if you pay for a year up front. The medication is billed separately at those manufacturer-matched prices.

More detail: Ro GLP-1 reviews · Ro GLP-1 cost breakdown

What we actually verified for this guide

How we ranked the best Saxenda alternatives

We ranked these by real-world replacement value, not popularity. The score weighs FDA-approved status, clinical-trial evidence, dosing convenience, access, price transparency, and — most important — how well each option solves the actual reason someone leaves Saxenda. Commercial partnerships never override FDA status, medical accuracy, or your fit. We use the RX Index Score methodology.

Our weighting:

• 25% — FDA-approved relevance to weight management
• 20% — fit for the common reasons people leave Saxenda
• 15% — dosing convenience (weekly/oral vs. daily)
• 15% — clarity of the access path
• 10% — current price transparency
• 10% — insurance/coverage support
• 5% — how clearly the drawbacks are disclosed

One editorial rule we hold: for this exact question, compounded products do not lead — because you’re starting from an FDA-approved medicine, and blurring FDA-approved with compounded would be both wrong and risky while the rules tighten in 2026.

Frequently asked questions

What can I take instead of Saxenda?

You can ask a clinician about Zepbound, Wegovy (pen or pill), Foundayo, or generic liraglutide, plus non-GLP-1 pills like Qsymia, Contrave, or orlistat. The best choice depends on whether you’re switching for cost, results, convenience, side effects, or coverage.

Is Zepbound better than Saxenda?

For most adults who want a weekly shot and bigger results, Zepbound (tirzepatide) is the stronger option — around 21% average weight loss at its top dose in its main trial versus about 8% for Saxenda. It is not automatically best if your insurance excludes it, you want a pill, or your clinician has a reason to choose differently.

Is Wegovy better than Saxenda?

Wegovy (semaglutide) is usually a better practical alternative because it’s weekly instead of daily and produced about 2.4 times more weight loss than Saxenda in a head-to-head trial (STEP 8). It also tends to have more insurance and savings pathways, though coverage still varies by plan.

Is there a pill alternative to Saxenda?

Yes — the Wegovy pill (oral semaglutide) and Foundayo (orforglipron) are FDA-approved weight-management tablets. The Wegovy pill needs an empty-stomach morning routine; Foundayo can be taken any time of day with or without food. Both let you skip injections entirely.

Is generic Saxenda available?

Yes. Generic liraglutide, the FDA-approved generic version of Saxenda, was approved and launched by Teva in August 2025 — the first generic GLP-1 for weight loss. It is the same medicine and can lower your cost, but it is still a daily injection.

What is the cheapest alternative to Saxenda?

The cheapest effective route is usually a brand-name GLP-1 bought direct: the Wegovy pill from $149/month, Zepbound vials from $299/month, or the Wegovy pen at $349/month through the makers’ pharmacies — all below Saxenda’s $1,349 list price. With insurance and a savings card, eligible patients may pay as little as $25/month.

Can I switch from Saxenda to Wegovy or Zepbound?

Often yes, but a clinician should guide the switch — you should not take two GLP-1s at once, and the timing depends on your dose and tolerance. Bring your current dose, last injection date, side effects, and budget to the conversation.

Are compounded GLP-1s alternatives to Saxenda?

They should not be presented as FDA-approved alternatives, generics, or “the same as” Saxenda — compounded drugs are not FDA-approved, and in 2026 the FDA is moving to restrict large-scale GLP-1 compounding. Discuss compounding only with a licensed clinician in specific situations where an approved drug isn’t an option.

Is Saxenda still worth using?

Yes, Saxenda can still be worth it if it’s working, you tolerate it, and the cost and coverage work for you. The main reasons people compare alternatives are the daily injection, the price, coverage changes, side effects, or wanting a weekly or oral option.

What is the closest alternative to Saxenda?

Generic liraglutide is the closest, because Saxenda’s medicine is liraglutide — same drug, same daily injection, usually a lower price. If you want something stronger or weekly instead, look to Wegovy or Zepbound.

Which Saxenda alternative should I ask my doctor about first?

Ask about Zepbound if your goal is the most weight loss, Wegovy if coverage or weekly semaglutide matters most, the Wegovy pill or Foundayo if you want a no-needle option, and generic liraglutide if Saxenda worked but cost too much.

Related reading

• Wegovy vs. Zepbound vs. Saxenda: full comparison
• Zepbound vs. Wegovy head-to-head
• Best Wegovy alternatives 2026
• Best Zepbound alternatives 2026
• Best Mounjaro alternatives 2026
• How to get the Wegovy pill online
• Foundayo cost without insurance
• Best Foundayo providers
• Best GLP-1 for sleep apnea
• Compounded GLP-1 vs. name brand
• Best GLP-1 online programs
• Ro GLP-1 reviews

The bottom line on the best Saxenda alternatives

For most U.S. adults, the best Saxenda alternative is Zepbound if you want the most weight loss and the price or coverage works, or Wegovy if you want a proven weekly shot with more insurance options. If needles are the dealbreaker, the Wegovy pill and Foundayo are FDA-approved pills. If Saxenda worked but cost too much, generic liraglutide is the closest cheaper version. And the quiet truth underneath all of it: the better drug is usually the cheaper one now too — so switching off Saxenda often means more results and a smaller bill.

Whatever your reason for leaving Saxenda, there’s a fit — and a clinician makes the final call on what’s right and safe for you.

Sources

1. U.S. Food and Drug Administration — FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on the 503B Bulks List (April 30, 2026); FDA prescribing information for Saxenda, Wegovy (pen and pill), Zepbound, and Foundayo; FDA warnings to telehealth companies on compounded GLP-1 marketing.
2. Teva Pharmaceuticals — FDA Approval and Launch of Generic Saxenda (liraglutide injection), August 2025; Teva liraglutide savings program.
3. Novo Nordisk / NovoCare — Wegovy pen and Wegovy pill self-pay and savings pricing; Saxenda list price ($1,349.02); FDA Approves Wegovy Pill (December 2025); OASIS 4 results.
4. Eli Lilly / LillyDirect — Lilly Lowers the Price of Zepbound Single-Dose Vials (December 2025); FDA Approves Foundayo (orforglipron) (April 1, 2026) and self-pay pricing.
5. New England Journal of Medicine — STEP 1 (2021), SURMOUNT-1 (2022), OASIS 4 (2025); JAMA — STEP 8 (2022).
6. Centers for Medicare & Medicaid Services — Medicare GLP-1 Bridge demonstration (effective July 1, 2026).
7. GoodRx, SingleCare, Drugs.com — current Saxenda, generic liraglutide, Qsymia, and phentermine pricing and coupons.

About this guide: The RX Index is independent guidance for choosing your GLP-1 path. We score providers and treatment routes on what actually matters — clinical legitimacy, care quality, transparency, access, and cost — then help you decide where to start. We compared FDA approvals and prescribing information, published clinical-trial results (SCALE, STEP 1, STEP 8, SURMOUNT-1, OASIS 4, and Foundayo’s Trial 1), current pricing from NovoCare and LillyDirect, the FDA’s 2026 compounding proposal, and the real reasons people search for Saxenda alternatives. This page is educational and does not replace care from a licensed clinician.

Last verified: June 17, 2026. Some links go to partners who pay us a commission; this never changes our rankings or the facts.